Literature DB >> 12723795

Disposition of sulfadimethoxine in male llamas (Llama glama) after single intravenous and oral administrations.

Kathryn Junkins1, Dawn Merton Boothe, James Jensen, Tanya Herzog, Jenifer Chatfield.   

Abstract

This study determined the disposition of sulfadimethoxine in six, healthy, adult, gelded male llamas (Llama glama) by using a nonrandomized crossover design with i.v. dosing (58.8 +/- 3.0 mg/kg based on metabolic scaling) followed by oral dosing (59.3 mg/kg +/- 8.3). Blood samples were collected intermittently for a 72-hr period, and serum sulfadimethoxine concentrations were quantified using high-performance liquid chromatography. Serum sulfadimethoxine concentrations across time were subjected to standard pharmacokinetic analysis based on linear regression. Mean maximum serum concentration after oral dosing was 23.6 +/- 14.9 microg/ml, and extrapolated peak concentration after i.v. administration was 246.6 +/- 15.8 microg/ml. Total clearance of sulfadimethoxine was 45.4 +/- 13.9 L/kg. Half-lives after i.v. and oral administration were 541 +/- 111 min and 642.4 +/- 204.8 min, respectively. Oral bioavailability was 52.6 +/- 15%. These data suggest that the oral dose administered to llamas in this study, based on metabolic scaling from cattle, may be inadequate when compared with the reported minimum inhibitory concentration (512 microg/ml) breakpoint for sulfadimethoxine.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12723795     DOI: 10.1638/1042-7260(2003)34[0009:DOSIML]2.0.CO;2

Source DB:  PubMed          Journal:  J Zoo Wildl Med        ISSN: 1042-7260            Impact factor:   0.776


  2 in total

1.  Florfenicol pharmacokinetics in healthy adult alpacas after subcutaneous and intramuscular injection.

Authors:  K Holmes; D Bedenice; M G Papich
Journal:  J Vet Pharmacol Ther       Date:  2011-07-08       Impact factor: 1.786

2.  Bioavailability and pharmacokinetics of oral meloxicam in llamas.

Authors:  Amanda J Kreuder; Johann F Coetzee; Larry W Wulf; Jennifer A Schleining; Butch KuKanich; Lori L Layman; Paul J Plummer
Journal:  BMC Vet Res       Date:  2012-06-21       Impact factor: 2.741

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.